Andrew Badrot, CEO of C2 Pharma and a close observer of pharma industry trends, analyzes the current situation and how this pandemic may kick of changes in the pharma...
31.10.2013
- Trial And Error - Despite a 150-year history and an aggregate R&D expenditure of $150 billion per year, innovation in the modern pharmaceutical industry is essentially still based...
11.04.2013
- The Rise Of Generics - In 2011, CMS Pharma was invited to take part in a conference in Mumbai to discuss the emergence of "supergenerics," a new form of generic drugs with improved...
